Digoxin
NDC 51655-403, Digoxin, tablet, from Northwind Health Company, LLC.
- Product NDC
- 51655-403
- Status
- Listed
- Labeler
- Northwind Health Company, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215307
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51655-403 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIGOXIN.125 mg/1
Pharmacologic classes
Cardiac Glycoside [EPC]; Cardiac Glycosides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51655-403-52 | 51655040352 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-403-52) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f9897bec-c16f-2728-e053-6394a90aecb7
Use it
Look up 51655-403 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51655-403 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51655-403. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.